Intraocular Inflammation Linked to Faricimab Injections
Author Information
Author(s): Cozzi Mariano MSc, Ziegler Alexander MD, Fasler Katrin MD, Muth Daniel R. MD, Blaser Frank MD, Zweifel Sandrine A. MD PhD
Primary Institution: University Hospital Zurich, University of Zurich
Hypothesis
What are some characteristics and outcomes of sterile intraocular inflammation after injection of faricimab?
Conclusion
The study found that sterile intraocular inflammation can occur after faricimab injections, with some cases leading to severe vision loss.
Supporting Evidence
- 12 eyes from 7 patients developed intraocular inflammation after faricimab injections.
- 2 eyes developed retinal vasculitis, with one case leading to significant vision loss.
- The median number of injections before inflammation was 3.5.
- 3 eyes had increased intraocular pressure of 30 mm Hg or higher.
Takeaway
Some people can get eye inflammation after getting a specific eye injection, and in some cases, it can make their vision worse.
Methodology
This was a retrospective case series study analyzing patients referred for intraocular inflammation after faricimab injections.
Potential Biases
The retrospective design may introduce biases affecting the results.
Limitations
The study cannot establish causality and may have missed some moderate cases of inflammation that were treated elsewhere.
Participant Demographics
Mean age was 73.3 years, with 57.1% female and 42.9% male participants.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website